Why trade secrets require a business decision, not just a label
Trade secrets are confidential business information that may give your technology company a competitive advantage, including formulas, methods or processes. In Australia, however, “trade secret” is treated as a form of confidential information rather than a term with a clear or rigid statutory definition. The label alone does not establish protection.
The practical question is whether your business has identified information that matters commercially and managed it as confidential. Registered IP rights usually involve a formal registration system. Trade secrets depend on continued secrecy, controlled access and sensible handling of disclosure. Active management is therefore part of maintaining their value and protecting them from leakage or misappropriation.
For a technology CEO, the decision can be framed in five steps:
- Identify the information that gives the business an advantage or supports a valuable product, service or process.
- Record why the information matters and who needs access to it.
- Examine how the information is stored, shared and received from outside the company.
- Decide whether secrecy remains commercially appropriate alongside other IP protection.
- Escalate legal, commercialisation or value questions before a significant disclosure, licence, transaction or investment discussion.
That framework helps you distinguish an important business asset from information that has merely been described as secret.
A practical triage for technology information
A practical triage for technology information starts with the information itself, not with the name attached to it. A software company might examine source material, a process, a formula, a technical workflow or another body of know-how that supports its product or operations. An example is not automatically a trade secret; the business must examine its character, circumstances and controls.
Use this sequence when reviewing an information set:
- Describe it specifically. State what the information is without using a vague category such as “all company information”. A precise description makes access, disclosure and contractual controls easier to assess.
- Explain the commercial connection. Record how the information supports a product, process, service, operating advantage or planned commercial activity.
- Map the secrecy conditions. Identify who knows it, how they received it, where it is stored and whether external recipients were subject to a confidentiality obligation.
- Test the disclosure path. Note whether the information has been shared with staff, contractors, advisers, potential partners, customers, manufacturers, investors or acquirers.
- Choose the next question. A legal question concerns confidentiality obligations or possible misuse. A commercial question concerns licensing, sale or collaboration. A value question concerns what the information may contribute to a wider IP or business decision.
For an Australian breach-of-confidence action, information must have the necessary quality of confidence and be received in circumstances importing an obligation of confidence. The triage therefore produces a disciplined review; it does not confirm that particular information qualifies.

What makes information potentially protectable in Australia
Australian trade-secret protection is closely tied to confidential information and the circumstances in which that information is held or disclosed. Australian law does not give “trade secret” a clear or rigid definition. The same business description may therefore need to be examined through the facts surrounding the information rather than through a label in an internal register or contract.
For an Australian breach-of-confidence action, the information must have the necessary quality of confidence and must have been received in circumstances importing an obligation of confidence. Those two ideas give you a useful initial test:
- Circumstances of confidence: the way the information was received, shared or entrusted should support an obligation to keep it confidential.
Your internal review should connect those ideas to business records. Describe the information with enough specificity to distinguish it from ordinary know-how, identify the people and organisations with access, and record the purpose for which it was disclosed. Examine whether contracts, confidentiality arrangements or the surrounding circumstances establish an obligation of confidence.
This review is particularly relevant when a product combines technical information with operational knowledge. A business may possess confidential information without every part of its technology receiving the same treatment. Separate the information into sensible categories and assess each category on its own facts. A legal adviser can then consider the applicable circumstances without relying on an overbroad description.
Trade secrets compared with other IP choices
Trade secrets, patents, copyright, trademarks and general confidential information address different business questions. The comparison below is a high-level decision aid rather than a conclusion about which form of protection suits your technology.
| IP choice | What it addresses | Main condition or feature | Practical exposure |
|---|---|---|---|
| Trade secret | Confidential information that gives a business a competitive advantage | Continued secrecy and active management | It does not give an exclusive right to exclude all third parties from commercial use |
| Patent | Qualifying functions or features of a device, substance, method or process | An Australian patent must be granted to be legally enforceable as a right to commercially exploit the invention | Public disclosure can affect the ability to keep an invention secret and may prevent patent protection |
| Copyright | A separate category of intellectual property considered alongside other IP rights | It should not be treated as a substitute for controls over confidential technical information | A company still needs to manage confidential information that is not addressed by copyright |
| Trademark | A sign used to distinguish goods or services from those of another trader | Protection concerns the distinguishing sign rather than secret technical know-how | A trademark does not make a technical process confidential |
| General confidential information | Business information handled as confidential | The information and the circumstances must support confidence | A broad label may not identify what must be protected or who may access it |
Trade-secret protection depends on maintaining secrecy and using confidentiality agreements. If an invention is publicly shared, competitors may be able to use the details and patent protection may no longer be available. A granted Australian patent, by contrast, can provide exclusive rights for qualifying functions or features. Your IP plan may use more than one form of protection, but each choice requires its own conditions and controls.
The control system a technology company can put in place
A technology company can protect confidential information through a connected control system covering disclosure, access, storage and monitoring. The system should be practical enough for your team to use consistently.
Consider the following controls:
- Use a confidentiality agreement before disclosure. Do not disclose confidential information to an intended recipient without first having a confidentiality agreement in place. The agreement should relate to the purpose of the proposed disclosure.
- Apply need-to-know access. Give employees access only to the confidential information required for their jobs. Different teams may need access to different information categories.
- Secure the information. Keep IP and confidential information in secure locations and in a secure manner. Your storage arrangements should reflect the sensitivity of the information.
- Mark shared material. Mark documents and other materials provided to third parties as confidential so the intended character of the information is clear.
- Monitor agreements. Store and monitor non-disclosure agreements, including their purpose, parties and relevant expiry dates.
- Treat outside information cautiously. Information received from another company, collaborator or prospective partner should be handled carefully because it may belong to a third party and may carry restrictions on use.
A contract is not a complete control system by itself. Contractual confidentiality enforcement depends on having an applicable confidentiality clause; without one, another legal basis may be required. Access, storage and document practices should support the obligations your agreements create.
An operating record makes the control system easier to apply. For each important information category, record its description, business purpose, authorised access group, storage location, external recipients and applicable confidentiality arrangement. Review the record when the information moves between teams or is prepared for external use. The record is a management aid, not a legal determination.

Controls must follow the information through its lifecycle
Trade-secret controls must follow information through its lifecycle because the business, technology and disclosure context can change. Unlike registered IP rights, trade-secret value can shift with technology and market conditions, while leakage and misappropriation can undermine protection.
A useful lifecycle review covers four stages:
- Creation: identify new technical or operational information and record why it may matter to the business.
- Use: limit access to the people who need the information for their work and keep it in secure locations.
- Disclosure: define the purpose of sharing, use a confidentiality agreement before disclosure and mark the material as confidential.
- Change or exit: review access, agreements and commercial relevance when technology develops, business goals change or an external arrangement ends.
The value of trade secrets can be affected by market trends and technological development. An exploitation strategy should therefore evolve with the organisation’s business goals rather than remaining fixed after the first agreement is signed. A process that suited an early product may need review when the company adds a partner, changes its technical architecture, prepares for licensing or enters transaction discussions.
Agreement monitoring is part of the lifecycle. Store and monitor non-disclosure agreements and their expiry dates, while keeping track of the material and purpose covered by each agreement. When a disclosure arrangement changes, reassess the information and the controls around it.
Where secrecy protection stops
Trade-secret protection has defined limits that matter when your product, code, process or know-how reaches the market. Trade-secret protection does not provide an exclusive right to exclude third parties from commercial use. Patents and utility models can provide that type of protection.
The main boundaries are these:
- Public disclosure: Once a secret is made public, anyone may access and use it. Trade-secret protection operates only against illicit acquisition, use or disclosure of confidential information.
- Reverse engineering: If a secret embodied in an innovative product can be reverse engineered, others may discover it and be entitled to use it.
- Independent development: Information may be patented by someone else who developed it through legitimate means, including independent development.
- Proof and enforcement: Trade secrets are generally more difficult to enforce than patents because proving a violation can be difficult.
These limits affect product design and commercial planning. If a product reveals the relevant information through inspection or analysis, secrecy may not provide the exclusion that your business needs. If the commercial plan depends on preventing others from using a qualifying invention, examine patent protection before public disclosure. That decision requires legal input because the relevant facts and timing determine the available choices.
A confidentiality control can reduce the risk of unauthorised disclosure, but it cannot turn every form of lawful discovery or independent development into misuse. Build the limits into your planning before relying on secrecy as the main protection.
Disclosure, collaboration, and third-party information
Disclosure, collaboration and third-party information create separate questions about purpose, permission and responsibility. A technology company may need to share information with a contractor, manufacturer, research partner, investor, licensee or prospective acquirer, but the commercial purpose does not remove the need for controlled handling.
Before sharing your confidential information, work through this sequence:
- Define why the recipient needs the information and what use is permitted.
- Put an applicable confidentiality agreement in place before disclosure.
- Mark the materials as confidential and keep a record of what was shared.
- Store and monitor the non-disclosure agreement, including any time limit.
- Reassess the arrangement if the purpose, recipient or information changes.
Depending on the applicable law, trade-secret protection may arise under specific trade-secret laws, unfair-competition laws, common-law duties of confidence or contracts.
Information received from outside the company needs a separate intake process. Treat it cautiously so your business does not use or disclose another party’s trade secret in a way that may create a misappropriation risk. Record the source, permitted purpose and restrictions before the information enters product development, sales material or internal systems.
A collaboration can be commercially useful while still requiring boundaries. Use the agreement and the disclosure record to keep your team clear about what it may use, what it must protect and what remains outside the agreed purpose.

From protected know-how to commercialisation
Trade secrets can support commercialisation when you connect the information to a defined business purpose. Trade secrets can be used alone, shared with others or assigned to others, and their strategy can be considered alongside other IP rights.
For an Australian technology company, possible commercial settings include:
- Internal use: confidential know-how may support a product, operating process or technical service without being disclosed outside the business.
- Licensing: a controlled disclosure may allow another party to use the information for an agreed purpose while the business retains an interest in how it is handled.
- Partnerships: a collaboration may combine your confidential information with another party’s resources, subject to clear disclosure and use arrangements.
- Transaction planning: confidential technology information may form part of discussions about a sale, acquisition, investment or broader business transaction.
The commercial question is not simply whether information is secret. You also need to understand what role it plays, who can use it, what may be shared and how the arrangement fits with your wider IP position. Market trends and technological development can affect the value of trade secrets, so an exploitation strategy should evolve with the organisation’s business goals.
Treat commercialisation as a controlled decision. Identify the information, establish the permitted purpose, document the confidentiality arrangement and obtain appropriate input before disclosing material that may affect the company’s negotiating position or future options.
Separate legal status from commercial value
Legal status and commercial value are separate questions about the same information. Legal analysis asks whether the information has the necessary quality of confidence and was received in circumstances importing an obligation of confidence. Commercial analysis asks how the information contributes to protection, exploitation, licensing, a transaction or another business decision.
Understanding the value of your trade secrets can support informed decisions about their protection and exploitation. That does not confirm that the information qualifies as a trade secret, establish that another party has breached an obligation or determine what your company would receive in a transaction.
Keep the questions separate in your internal review:
| Question | What you are trying to understand |
|---|---|
| What is the information? | Its specific content, business purpose and relationship to the technology or operation |
| What confidentiality conditions apply? | Access, disclosure circumstances, agreements and handling controls |
| What commercial role does it have? | Its contribution to a product, service, licence, partnership or transaction |
| What value question needs answering? | The decision for which a value assessment may be relevant |
Separating these questions prevents a value discussion from being treated as proof of legal protection. It also prevents a legal confidentiality review from being mistaken for an individualised valuation. The two forms of professional input may inform one another, but they answer different questions.
When professional input becomes appropriate
Qualified legal input becomes appropriate when the consequences of disclosure, collaboration or possible misuse need to be assessed against the specific facts. Consider seeking it before you disclose sensitive information without a clear confidentiality arrangement, receive another party’s technical material, negotiate disputed use, prepare for a possible enforcement step or decide whether public disclosure affects another IP option.
The legal question may involve the information’s quality of confidence, the circumstances in which it was received, the terms of an agreement and the legal basis available under the applicable law. A general description such as “our technology” is not a substitute for examining the particular information and transaction.
Commercialisation or valuation input becomes appropriate when you are considering licensing, sale, transaction planning, investment or a wider IP strategy. Understanding the value of trade secrets can support decisions about their protection and exploitation, but the exercise should be tied to a defined decision rather than treated as a standalone label.
We offer specialist valuations for patents, trademarks, data assets, R&D pipelines and proprietary platforms. We have deep IP specialisation across valuations, licensing and sales, and we provide AFSL-licensed valuations of businesses, IP and AI technology. If you seek a valuation, the valuer selects the method case by case for the information and decision being assessed. We do not determine whether particular information has legal trade-secret status.
Confidential follow-up for an Australian technology business
An Australian technology business considering IP value or commercialisation input can separate its immediate need before starting a discussion. You may need to understand the potential value of patents, data assets, R&D pipelines or proprietary platforms; prepare for licensing; or plan a confidential sale process for IP or the business built on it.
We offer specialist valuations across those IP assets, have deep IP specialisation across valuations, licensing and sales, and structure and negotiate licensing arrangements that protect IP and capture its commercial value. We also run structured, confidential sale processes for intellectual property and the businesses built on it. Our valuations are AFSL-licensed under Licence No. 563351.
Prepare a short commercial brief before seeking input:
- Identify the information or IP asset under discussion.
- State the business decision that requires input.
- Describe who has access and what has already been disclosed.
- List relevant confidentiality arrangements and external recipients.
- Separate any legal-status question from the commercial or value question.
This approach keeps the conversation focused on the decision you need to make without treating a commercial assessment as confirmation of legal trade-secret status.
A CEO’s next-action checklist
A CEO’s next-action checklist should turn protection of sensitive information into a repeatable business review. List the information. Describe sensitive formulas, methods, processes, technical material and other confidential information specifically.
2. Record why it matters. Note the product, service, process or commercial decision connected with each information category.
3. Map access and disclosure. Identify internal access, external recipients, the purpose of each disclosure and information received from outside the business.
4. Check controls. Confirm that access is limited on a need-to-know basis, information is stored securely and shared material is marked confidential.
5. Check agreements. Store and monitor non-disclosure agreements and their expiry dates. Do not disclose confidential information without an applicable confidentiality agreement with the intended recipient.
6. Review the commercial choice. Decide whether continued secrecy remains appropriate alongside other IP protection, licensing, collaboration or transaction plans.
7. Escalate the right question. Obtain qualified legal advice for confidentiality, disclosure or enforcement issues, and commercial or valuation input for licensing, sale, investment or value decisions. No general article can decide whether your information qualifies as a trade secret or what it is worth.
The useful outcome is a clear record of what matters, how it is controlled, where it has travelled and which decision requires professional input. Request a confidential, no-obligation follow-up.
A commercial review can help you organise the next decision about protection or exploitation, while the legal position and any value assessment remain questions for the relevant qualified professionals.
What should a technology CEO check before sharing confidential information?
What information may qualify as an intellectual property trade secret in Australia?
It may be specific confidential information that gives a technology business a competitive advantage, such as a formula, method, process or technical know-how. In Australia, the term is not rigidly defined by statute.
Does an NDA protect a trade secret by itself?
No. A non-disclosure agreement can establish or clarify confidentiality obligations for a particular disclosure, but it is only one part of a broader control system. Limit access on a need-to-know basis, secure the information, mark shared material as confidential, record what was disclosed and monitor the agreement’s scope and expiry. Legal advice may be appropriate when the agreement or disclosure is significant.
How can trade secrets affect an IP sale, licence or business transaction?
They can form part of a technology business’s commercialisation or transaction discussions, but disclosure should be tied to a defined purpose and controlled through appropriate confidentiality arrangements. Before sharing, identify the information, permitted use, recipient and access limits. A legal review addresses confidentiality and disclosure risks; a separate commercial or valuation assessment can consider the information’s contribution to a licensing, sale, investment or other business decision without determining legal trade-secret status.
